絞り込み

18403

広告

High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.

著者 Sun Q , Liang X , Zheng Q , Liu W , Xiao S , Gu W , Lu H
Helicobacter.2010 Jun ; 15(3):233-8.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Department of Gastroenterology, Shanghai Renji Hospital, Shanghai Institute of Digestive Disease, Shanghai Jiaotong University School of Medicine, China.

スターを付ける スターを付ける     (166view , 0users)
The success rate of currently recommended 7-day triple therapy with a PPI plus amoxicillin and clarithromycin has fallen into the unacceptable range. It is urgent to look for a new strategy to treat the infection of Helicobacter pylori.
PMID: 20557366 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード